Paper Details

  1. Home
  2. Paper Details

Nicotine receptor partial agonists for smoking cessation.

Author: FanshaweThomas R, HajizadehAnisa, HartmanLilian, LindsonNicola, Livingstone-BanksJonathan, TheodoulouAnnika, ThomasKyla H

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Nicotine receptor partial agonists, such as varenicline and cytisine, have been shown to help people stop smoking by balancing dopamine levels to reduce withdrawal symptoms and by decreasing smoking satisfaction.
Paper Details　
Original Abstract of the Article :
Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist). This is an update of a Cochrane Review first published ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169257/

データ提供：米国国立医学図書館（NLM）

Nicotine Receptor Partial Agonists: A New Approach to Smoking Cessation

The battle against [tobacco addiction] is an ongoing one, with researchers constantly seeking new and effective treatment strategies. This review focuses on the potential of [nicotine receptor partial agonists] as a smoking cessation aid. These agents act as both [agonists and antagonists], reducing withdrawal symptoms while simultaneously diminishing the satisfaction associated with smoking. The authors provide an updated overview of the research on this promising approach to smoking cessation.

Finding a Path Through the Desert of Addiction

Breaking free from the shackles of nicotine addiction can be a daunting task. This review suggests that [nicotine receptor partial agonists] may offer a more manageable path through the desert of addiction. By reducing withdrawal symptoms and curbing smoking satisfaction, these agents could help smokers navigate the challenging process of quitting.

A Beacon of Hope in the Desert of Addiction

This research offers a beacon of hope for smokers seeking to escape the clutches of nicotine addiction. By exploring the potential of [nicotine receptor partial agonists] as a smoking cessation aid, we can potentially pave a smoother path through the desert of addiction, enabling smokers to achieve freedom from nicotine's grip.

Dr. Camel's Conclusion

This review underscores the potential of nicotine receptor partial agonists as a promising approach to smoking cessation. By addressing both withdrawal symptoms and smoking satisfaction, these agents may offer a more effective and manageable path through the desert of addiction.

Date :
  1. Date Completed 2023-05-08
  2. Date Revised 2023-06-13
Further Info :

Pubmed ID

37142273

DOI: Digital Object Identifier

PMC10169257

Related Literature

Article Analysis
・Effective treatment of e-cigarettes
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.